Bleichroeder LP Infinity Pharmaceuticals, Inc. Transaction History

Bleichroeder LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	BUY	$0.77 - $1.13 $192,177 - $282,026	249,581 Added 59565.87%	250,000 $226,000
Q1 2020 May 14, 2020	SELL	$0.69 - $1.52 $344,710 - $759,363	-499,581 Reduced 99.92%	419 $0
Q4 2019 Feb 14, 2020	BUY	$0.88 - $1.29 $440,000 - $645,000	500,000 New	500,000 $480,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

Stay updated on Bleichroeder LP with notifications on news.